Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Abivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February
Abivax SA announced the organization of a virtual KOL Investor Event on February 6, 2024. The event will feature Marla Dubinsky, MD, and Parambir Dulai, MD. Along with Abivax?s management, they will.
EQS-News: ABIVAX / Key word(s): ConferenceAbivax to host KOL Investor Event to review phase 2b clinical data and phase 3 trial design for obefazimod in patients with moderately to severely active ulcerative colitis on February 6, 2024 24.01.2024 / 08:30 CET/CESTThe issuer is solely responsible for the content of thi.